| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974814 | The Journal of Heart and Lung Transplantation | 2005 | 8 Pages |
Abstract
These pilot results describe the pharmacokinetics of basiliximab and show that basiliximab appears to be tolerated with a similar safety profile to placebo in adult de novo heart transplant recipients. Larger scale clinical trials are feasible and warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mandeep R. MD, Mark J. MD, Lynne MD, Robert MD, John MD, John PhD, Arthur MD,